Catonsville, MD, United States of America

Shijun Zhong


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Ellicott City, MD (US) (2013)
  • Catonsville, MD (US) (2015 - 2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Shijun Zhong: Innovator in Cancer Treatment

Introduction

Shijun Zhong is a prominent inventor based in Catonsville, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of compounds that inhibit human DNA ligases. With a total of 3 patents, Zhong's work is paving the way for new therapeutic methods in oncology.

Latest Patents

Zhong's latest patents focus on compounds that inhibit human DNA ligases and methods of treating cancer. These patents include methods for treating cancer using these compounds, as well as techniques for providing insights into the reaction mechanisms of human DNA ligases. His work aims to identify the specific human DNA ligase involved in various DNA repair pathways. Additionally, he has developed screening methods for these compounds, further enhancing the potential for targeted cancer therapies.

Career Highlights

Throughout his career, Shijun Zhong has worked with notable institutions, including the University System of Maryland and Stc.unm. His research has garnered attention for its potential impact on cancer treatment, showcasing his dedication to advancing medical science.

Collaborations

Zhong has collaborated with esteemed colleagues such as Alan Edward Tomkinson and Barbara Dziegielewska. These partnerships have contributed to the depth and breadth of his research, fostering an environment of innovation and discovery.

Conclusion

Shijun Zhong's contributions to the field of cancer treatment through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to inspire advancements in medical research and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…